secwatch.observer — SEC 8-K summary
======================================

Issuer:     Keros Therapeutics, Inc. (KROS)
CIK:        0001664710
Form:       8-K
Filed at:   2024-06-03T23:59:59+00:00
Accession:  0001664710-24-000047
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Keros Therapeutics CEO to present at Goldman Sachs Healthcare Conference June 10
--------------------------------------------------------------------------------

- CEO Jasbir S. Seehra, Ph.D., to participate in fireside chat at Goldman Sachs 45th Annual Healthcare Conference.
- Presentation scheduled for June 10, 2024 at 2:40 p.m. Eastern time.
- Live webcast available; archived replay accessible for 90 days on Keros website.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1664710/000166471024000047/0001664710-24-000047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1664710/000166471024000047/kros-20240603.htm
  HTML page:      https://secwatch.observer/filing/0001664710-24-000047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer